Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pre-menopausal Breast Cancer × Alpelisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 33 Neoplasm Metastasis 8 Ovarian Neoplasms 5 Hereditary Sensory and Autonomic Neuropathies 5 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Neoplasms 4 Multiple Endocrine Neoplasia Type 1 3 Head and Neck Neoplasms 3 Triple Negative Breast Neoplasms 2 Pancreatic Neoplasms 2 Lymphatic Abnormalities 2 Lymphangioma, Cystic 2 Lymphangioma 2 Hyperglycemia 2 Endometrial Neoplasms 2 Advanced Breast Cancer 2 Vascular Malformations 1 Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein 1 Solid Tumor 1 Skin Diseases, Vascular 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pre-menopausal Breast Cancer 1 Oropharyngeal Neoplasms 1 Multiple Myeloma 1 Meningioma 1 Kidney Neoplasms 1 Hormone Receptor Positive Breast Carcinoma 1

Interventions

NVP-BKM120 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02058381 2020-03-09

B-YOND

Novartis

Phase 1 Completed

Pre-menopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡